| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2B | $3.2B | $0.8B | $0.9B | $0.6B | $0.5B | $0.4B | $0.4B |
| Cost of Revenue | $1.8B | $1.8B | $2.0B | $1.9B | $1.2B | $1.0B | $0.9B | $0.8B |
| Gross Profit | $1.4B | $1.5B | $0.3B | $0.4B | $0.3B | $0.2B | $0.2B | $0.2B |
| R&D Expense | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $0.5B | $0.4B | $0.6B | $0.5B | $0.3B | $0.3B | $0.3B | $0.2B |
| Operating Income | $0.5B | $0.5B | $0.5B | $0.5B | $0.6B | $0.4B | $0.2B | $0.3B |
| Net Income | $0.2B | $0.3B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $1.55 | $1.94 | $0.25 | $0.39 | $0.87 | $0.64 | $0.43 | $0.58 |
| EPS (Diluted) | $1.55 | $1.93 | $0.25 | $0.38 | $0.87 | $0.63 | $0.42 | $0.57 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.4B | $8.4B | $8.8B | $10.1B | $3.2B | $2.9B | $2.5B | $2.3B |
| Current Assets | $1.6B | $1.6B | $2.0B | $2.3B | $1.3B | $1.2B | $0.9B | $1.0B |
| Cash & Equivalents | $0.4B | $0.3B | $0.5B | $0.6B | $0.4B | $0.6B | $0.4B | $0.5B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.5B | $0.5B | $0.5B | $0.8B | $0.4B | $0.3B | $0.3B | $0.3B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.6B | $0.6B | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B |
| Investing Cash Flow | $-0.3B | $-0.1B | $0.6B | $-4.9B | $-0.3B | $-0.2B | $-0.4B | $-0.5B |
| Capital Expenditures | $0.3B | $0.3B | $0.5B | $0.5B | $0.2B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.4B | $-0.7B | $-1.3B | $4.8B | $-0.3B | $0.0B | $-0.1B | $0.0B |